Academia Sinica:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Academia Sinica - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9308
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Academia Sinica is an academic institution that promotes and undertakes research activities in the disciplines of mathematics and physical sciences, life sciences, humanities and social sciences, and others. The institution integrates research activities to improve the planning, implementation, and evaluation of long-term projects, improve the impact of the research activities; basic research results for applications and technology transfer; among others. Academia Sinica offers services in conducting scientific research in its own institutes, as well as providing guidance, channels of coordination, incentives to raise academic standards in the country, and others. The institution provides graduate and PhD programs in the areas of engineering, physical sciences, biological and agricultural sciences, humanities and social sciences, applied sciences and health and medical sciences, among others. Academia Sinica is headquartered in Taipei, Taiwan.

Academia Sinica – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Academia Sinica, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Academia Sinica, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Academia Sinica, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Academia Sinica, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Academia Sinica, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Academia Sinica, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
ASLAN Pharma Enters into Research Agreement with Academia Sinica’s Genomic Research Centre 10
Licensing Agreements 11
United BioPharma Enters into Licensing Agreement with Academia Sinica for Cancer 11
CHO Pharma Enters into Licensing Agreement with Academia Sinica 12
United BioPharma Enters into Licensing Agreement with Academia Sinica 13
Academia Sinica – Key Competitors 14
Academia Sinica – Key Employees 15
Academia Sinica – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Academia Sinica, Pharmaceuticals & Healthcare, Key Facts 2
Academia Sinica, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Academia Sinica, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Academia Sinica, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Academia Sinica, Deals By Therapy Area, 2012 to YTD 2018 8
Academia Sinica, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ASLAN Pharma Enters into Research Agreement with Academia Sinica's Genomic Research Centre 10
United BioPharma Enters into Licensing Agreement with Academia Sinica for Cancer 11
CHO Pharma Enters into Licensing Agreement with Academia Sinica 12
United BioPharma Enters into Licensing Agreement with Academia Sinica 13
Academia Sinica, Key Competitors 14
Academia Sinica, Key Employees 15

List of Figures
Academia Sinica, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Academia Sinica, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Academia Sinica, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Academia Sinica, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Academia Sinica, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Academia Sinica, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Academia Sinica, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Academia Sinica:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Drax Group Plc:企業の発電所・SWOT分析2018
    Drax Group Plc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • Western Farmers Electric Cooperative:企業の戦略的SWOT分析
    Western Farmers Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Vizrt Group AS:企業の戦略的SWOT分析
    Vizrt Group AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Arno Therapeutics Inc (ARNI)-医療機器分野:企業M&A・提携分析
    Summary Arno Therapeutics Inc (Arno) is a clinical stage biopharmaceutical company that develops products for the treatment of cancer, infectious diseases and other life threatening diseases. The company has exclusive worldwide rights for the development and commercialization of Onapristone (for the …
  • Walsin Lihwa Corporation:企業の戦略・SWOT・財務情報
    Walsin Lihwa Corporation - Strategy, SWOT and Corporate Finance Report Summary Walsin Lihwa Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Graham Packaging Company, L.P.:企業の戦略・SWOT・財務情報
    Graham Packaging Company, L.P. - Strategy, SWOT and Corporate Finance Report Summary Graham Packaging Company, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Galderma SA:医療機器:M&Aディール及び事業提携情報
    Summary Galderma SA (Galderma), a subsidiary of Nestle SA, is a pharmaceutical company that develops and markets drugs, medical dermatology solutions and therapeutic skin care products for the treatment of hair, nail, and skin diseases. Galderma offers products for the treatment of skin conditions s …
  • Tokyo Electron Limited:企業の戦略・SWOT・財務分析
    Tokyo Electron Limited - Strategy, SWOT and Corporate Finance Report Summary Tokyo Electron Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Patterson-UTI Energy Inc (PTEN):石油・ガス:M&Aディール及び事業提携情報
    Summary Patterson-UTI Energy Inc (Patterson) is an oilfield service provider. It offers onshore contract drilling and pressure pumping services to oil and gas exploration and production companies. The company offers pressure pumping services such as well stimulation and cementing for completion of n …
  • AlloSource:企業の戦略的SWOT分析
    AlloSource - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • 3I Group Plc:企業の戦略・SWOT・財務分析
    3I Group Plc - Strategy, SWOT and Corporate Finance Report Summary 3I Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Postnl N.V.:企業の戦略・SWOT・財務分析
    Postnl N.V. - Strategy, SWOT and Corporate Finance Report Summary Postnl N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • First Gen Corporation:発電所・企業SWOT分析
    First Gen Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employe …
  • OpenWay Group:企業の戦略的SWOT分析
    OpenWay Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Invenergy LLC:企業の戦略的SWOT分析
    Invenergy LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Bio-Path Holdings Inc (BPTH):企業の財務・戦略的SWOT分析
    Summary Bio-Path Holdings Inc (Bio-Path) is a clinical stage biotechnology company that develops targeted therapies for acute myeloid leukemia (AML), chronic myeloid leukemia (CML) and other challenging cancers. The company provides products pipeline such as prexigebersen (Liposomal Grb2 Antisense) …
  • Petronas Dagangan Berhad (PETDAG):石油・ガス:M&Aディール及び事業提携情報
    Summary Petronas Dagangan Bhd (Petronas Dagangan), a subsidiary of Petroliam Nasional Berhad, is an oil and gas company that retails and markets downstream oil and gas products. The company operates through its business segments such as retail, commercial, liquefied petroleum gas and lubricants. It …
  • BBVA:企業のM&A・事業提携・投資動向
    BBVA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BBVA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings …
  • Desitin Arzneimittel GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Desitin Arzneimittel GmbH (Desitin) formerly Desitin Compagnie mbH, is a specialty pharmaceutical company which develops and produces products for the treatment of central nervous system (CNS) related neurological and psychiatric diseases. Its product portfolio includes antiepileptic drugs a …
  • Oxford Immunotec Ltd:企業の製品パイプライン分析
    Summary Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.T …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆